Subscription Form

Name *

Country *

Email ID *

Contact Number

Domain of Interest

Therapy Area of Interest

Indication of Interest

Message

2nd Floor,

123 Kakrola Complex

Sector 15 Dwarka

Dwarka Mor, New Delhi,

INDIA - 110075

To discuss how we can support you, please get in touch via:

AbbVie Signs a Partner and Option to Acquire Agreement with TeneoOne for its TNB-383B
Roche Reports Results of Venclexta/Venclyxto (venetoclax) in P-III CLL14 Study for CLL
BeiGene and SpringWorks Globally Signs Clinical Agreement to Target Advanced Solid Tumours
AbbVie Reports FDA’s Hold on All Clinical Trials Evaluating Venclexta/Venclyxto (venetoclax) for Multiple Myeloma
Roche to Acquire Spark Therapeutics for $4.3B

Octavus ConsultingFollow

PharmaShots Weekly Snapshot (Sept 14 -18, 2020) @Pharmashot
https://pharmashots.com/48796/pharmashots-weekly-snapshot-sept-14-18-2020/

Name *

Email *

Comment or Message *

Comment